US OptionsDetailed Quotes

ARQT241018C7500

Watchlist

1.83
+0.08+4.57%

15min DelayClose Sep 27 15:59 ET

1.83High1.83Low

Arcutis Biotherapeutics Stock Discussion

Teddy123

Sep 25 13:03

New Data Shows ZORYVE® (Roflumilast) Cream 0.15% Provided Consistent Improvement of Atopic Dermatitis in Individuals With Diverse Skin Types

$Arcutis Biotherapeutics (ARQT.US)$
New Data Shows ZORYVE® (Roflumilast) Cream 0.15% Provided Consistent Improvement of Atopic Dermatitis in Individuals With Diverse Skin Types | ARQT Stock News

demonandevil

Sep 4 22:59

$Arcutis Biotherapeutics (ARQT.US)$ keep testing high

demonandevil

Aug 29 22:49

$Arcutis Biotherapeutics (ARQT.US)$ 11 , going to moon

Trytosaveabit

Aug 28 20:21

Update

$Arcutis Biotherapeutics (ARQT.US)$ Arcutis Biotherapeutics Inc -No New Safety Signals Observed During 56 Weeks of Treatment! Plans to submit sNDA to FDA in Q1 2025

103387577

Aug 19 23:19

easy

Share Your Profit/Loss

MommaCrazy

Aug 15 04:08

$Arcutis Biotherapeutics (ARQT.US)$ was hoping for better EPS. Revenue is awesome... getting there.

Jaguar8

Aug 15 04:02

NEWS ER

$Arcutis Biotherapeutics (ARQT.US)$
Arcutis Biotherapeutics reported strong Q2 2024 financial results, with net product revenues of $30.9M for the ZORYVE franchise, representing a 547% increase year-over-year and 43% growth quarter-over-quarter. The company saw improved gross-to-net (GTN) margins, now in the high 50% range. Arcutis entered a co-promotion agreement with Kowa Pharmaceuticals to expand ZORYVE's reach in primary care and pediatric offices. They also submitted an sNDA for ZORYV...

Hundred Bag

Jul 11 22:56

$Arcutis Biotherapeutics (ARQT.US)$

skinnydippi

Jul 11 07:37

$Arcutis Biotherapeutics (ARQT.US)$ everyone... let's get this up tomorrow

MangoXXXX

Jul 10 22:09

$Arcutis Biotherapeutics (ARQT.US)$ hopefully this will go back up later. 😁

No comment yet